Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Early metabolic resuscitation for pediatric septic shock
ACTRN12619000829112Phase 2Completed
- Sponsor
- The University of Queensland
- Start
- Aug 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of hydrocortisone, ascorbic acid and thiamine in sepsis and septic shock (2 arms), sponsored by The University of Queensland. Primary endpoints: Protocol compliance feasibility outcome and Survival free of organ dysfunction. Started Aug 2019; status: completed.
02
Drugs
hydrocortisoneascorbic acidthiamine
03
Conditions
sepsisseptic shock
Beyond the preview
Go deeper on ACTRN12619000829112.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12619000829112.